In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Milestone Scientific Inc (AMEX: MLSS) closed the day trading at $0.52 down -3.55% from the previous closing price of $0.54. In other words, the price has decreased by -$3.55 from its previous closing price. On the day, 0.59 million shares were traded. MLSS stock price reached its highest trading level at $0.545 during the session, while it also had its lowest trading level at $0.45.
Ratios:
For a better understanding of MLSS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 2.03. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.28.
On November 16, 2018, Maxim Group reiterated its Buy rating and also upped its target price recommendation from $3 to $1.50.
Maxim Group reiterated its Buy rating for the stock on December 23, 2016, while the target price for the stock was revised from $5 to $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 11 ’25 when BP4 S.r.l. sold 10,000 shares for $0.59 per share. The transaction valued at 5,940 led to the insider holds 9,256,972 shares of the business.
BP4 S.r.l. bought 400,000 shares of MLSS for $236,000 on Sep 10 ’25. On Jul 17 ’25, another insider, BP4 S.r.l., who serves as the 10% Owner of the company, sold 10,000 shares for $0.64 each. As a result, the insider received 6,400 and left with 9,298,724 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MLSS now has a Market Capitalization of 40748632 and an Enterprise Value of 40560868. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.49 while its Price-to-Book (P/B) ratio in mrq is 12.20. Its current Enterprise Value per Revenue stands at 4.465 whereas that against EBITDA is -5.846.
Stock Price History:
The Beta on a monthly basis for MLSS is 0.91, which has changed by -0.46391755 over the last 52 weeks, in comparison to a change of 0.1653893 over the same period for the S&P500. Over the past 52 weeks, MLSS has reached a high of $1.39, while it has fallen to a 52-week low of $0.38. The 50-Day Moving Average of the stock is -12.10%, while the 200-Day Moving Average is calculated to be -40.71%.
Shares Statistics:
Over the past 3-months, MLSS traded about 359.11K shares per day on average, while over the past 10 days, MLSS traded about 131820 shares per day. A total of 78.56M shares are outstanding, with a floating share count of 50.52M. Insiders hold about 35.75% of the company’s shares, while institutions hold 5.96% stake in the company. Shares short for MLSS as of 1756425600 were 184690 with a Short Ratio of 0.51, compared to 1753920000 on 112143. Therefore, it implies a Short% of Shares Outstanding of 184690 and a Short% of Float of 0.3.
Earnings Estimates
Its stock is currently analyzed by 1.0 different market analysts. The consensus estimate for the next quarter is $0.0, with high estimates of $0.0 and low estimates of $0.0.
Analysts are recommending an EPS of between -$0.06 and -$0.06 for the fiscal current year, implying an average EPS of -$0.06. EPS for the following year is -$0.03, with 1.0 analysts recommending between -$0.03 and -$0.03.
Revenue Estimates
2 analysts predict $2.25M in revenue for. The current quarter. It ranges from a high estimate of $2.3M to a low estimate of $2.21M. As of. The current estimate, Milestone Scientific Inc’s year-ago sales were $2.51MFor the next quarter, 2 analysts are estimating revenue of $2.99M. There is a high estimate of $3.5M for the next quarter, whereas the lowest estimate is $2.48M.
A total of 2 analysts have provided revenue estimates for MLSS’s current fiscal year. The highest revenue estimate was $10.4M, while the lowest revenue estimate was $9.24M, resulting in an average revenue estimate of $9.82M. In the same quarter a year ago, actual revenue was $8.63MBased on 2 analysts’ estimates, the company’s revenue will be $11.27M in the next fiscal year. The high estimate is $12.6M and the low estimate is $9.93M.
